sch 42495 has been researched along with guanosine monophosphate in 1 studies
Studies (sch 42495) | Trials (sch 42495) | Recent Studies (post-2010) (sch 42495) | Studies (guanosine monophosphate) | Trials (guanosine monophosphate) | Recent Studies (post-2010) (guanosine monophosphate) |
---|---|---|---|---|---|
18 | 5 | 0 | 1,526 | 20 | 325 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crozier, IG; Espiner, EA; Frampton, C; Ikram, H; Kosoglou, T; Nicholls, MG; Rallings, M; Richards, AM; Yandle, TG | 1 |
1 trial(s) available for sch 42495 and guanosine monophosphate
Article | Year |
---|---|
Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Guanosine Monophosphate; Heart Rate; Humans; Hypertension; Male; Methionine; Middle Aged; Natriuresis; Neprilysin; Norepinephrine; Renin-Angiotensin System; Sodium; Sympathetic Nervous System; Time Factors | 1993 |